Biogen Inc. (BIIB)

NasdaqGS Currently down 35.00 (-15.68%) in today's trading session

Track congressional stock trades in Biogen Inc. (BIIB). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Biogen Inc. is currently trading at $188.24, positioned at 85% of its 52-week range ($110.04 – $202.41). View which politicians have recently bought or sold BIIB and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$188.24
24h Change
-35.00 (-15.68%)
52 Week Range
$110.04$202.41
View on NASDAQ

Biogen Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BIIB

Select to highlight on chart
2 transactions
Compliance: 100%
Josh Gottheimer18 Oct 202115 Nov 2021PurchaseStock$1,001 - $15,000N/A (Price Data Unavailable)
Josh Gottheimer15 Sept 202113 Oct 2021SaleStock$1,001 - $15,000N/A (Sale Transaction)

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$27.63B

Volume

651.62K

Beta

0.14

P/E Ratio

21.44

Fundamentals

EPS

$8.78

Div. Yield

Open

$183.91

Day Range

$182.60 — $188.41

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ · USD
Country
US
CEO
Christopher A. Viehbacher
IPO Date
1991-09-17

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for s...

Earnings

Next Report

Q1 2026

30 Apr

EPS Est.

$3.04

Rev. Est.

$2.2B

Days Until

51

Recent Quarters

Q4 20256 Feb
EPS$1.99
Beat 22.1%
Q3 202530 Oct
EPS$4.81
Beat 24.0%
Q2 202531 Jul
EPS$5.47
Beat 40.3%
Q1 20251 May
EPS$3.02
Beat 4.1%
Q4 202412 Feb
EPS$3.44
Beat 0.3%
Q3 202430 Oct
EPS$4.08
Beat 8.2%
Q2 20241 Aug
EPS$5.28
Beat 29.7%
Q1 202424 Apr
EPS$3.67
Beat 5.8%
Q4 202313 Feb
EPS$2.95
Miss 6.7%
Q3 20238 Nov
EPS$4.36
Beat 9.3%
Q2 202325 Jul
EPS$4.02
Beat 6.6%
Q1 202325 Apr
EPS$3.40
Beat 3.7%
Q4 202215 Feb
EPS$4.05
Beat 16.4%
Q3 202225 Oct
EPS$4.77
Beat 15.5%
Q2 202220 Jul
EPS$5.25
Beat 29.3%
Q1 20223 May
EPS$3.62
Miss 17.9%
Q4 20213 Feb
EPS$3.39
Beat 2.1%
Q3 202120 Oct
EPS$4.77
Beat 14.9%
Q2 202122 Jul
EPS$5.68
Beat 24.3%
Q1 202122 Apr
EPS$5.34
Beat 5.5%
Q4 20203 Feb
EPS$4.58
Miss 7.1%
Q3 202021 Oct
EPS$8.84
Beat 9.7%
Q2 202022 Jul
EPS$10.26
Beat 27.8%
Q1 202022 Apr
EPS$9.14
Beat 18.2%
Q4 201930 Jan
EPS$8.34
Beat 4.0%
Q3 201922 Oct
EPS$9.17
Beat 10.9%
Q2 201923 Jul
EPS$9.15
Beat 21.5%
Q1 201924 Apr
EPS$6.98
Beat 1.6%
Q4 201829 Jan
EPS$6.99
Beat 4.0%
Q3 201823 Oct
EPS$7.40
Beat 9.1%
Q2 201824 Jul
EPS$5.80
Beat 11.1%
Q1 201824 Apr
EPS$6.05
Beat 1.9%
Q4 201725 Jan
EPS$5.26
Miss 3.3%
Q3 201724 Oct
EPS$6.31
Beat 10.1%
Q2 201725 Jul
EPS$5.04
Beat 14.3%
Q1 201725 Apr
EPS$5.20
Beat 4.6%
Q4 201626 Jan
EPS$5.04
Beat 1.4%
Q3 201626 Oct
EPS$5.19
Beat 4.4%
Q2 201621 Jul
EPS$5.21
Beat 11.6%
Q1 201621 Apr
EPS$4.79
Beat 7.2%
Q4 201527 Jan
EPS$4.50
Beat 10.3%
Q3 201521 Oct
EPS$4.48
Beat 17.9%
Q2 201524 Jul
EPS$4.22
Beat 2.9%
Q1 201524 Apr
EPS$3.82
Miss 2.3%
Q4 201429 Jan
EPS$4.09
Beat 8.2%
Q3 201422 Oct
EPS$3.80
Beat 9.8%
Q2 201423 Jul
EPS$3.34
Beat 18.0%
Q1 201423 Apr
EPS$2.47
Miss 3.1%
Q4 201329 Jan
EPS$2.34
Beat 2.6%
Q3 201328 Oct
EPS$2.35
Beat 11.9%
Q2 201325 Jul
EPS$2.30
Beat 19.2%
Q1 201325 Apr
EPS$1.97
Beat 22.4%
Q4 201228 Jan
EPS$1.40
Miss 4.1%
Q3 201225 Oct
EPS$1.91
Beat 19.4%
Q2 201224 Jul
EPS$1.82
Beat 16.7%
Q1 20121 May
EPS$1.40
Miss 5.4%
Q4 201131 Jan
EPS$1.51
Beat 1.3%
Q3 201128 Oct
EPS$1.61
Beat 5.2%
Q2 201126 Jul
EPS$1.36
Miss 0.7%
Q1 201121 Apr
EPS$1.43
Beat 1.4%
Q4 20101 Feb
EPS$1.42
Beat 15.4%
Q3 201026 Oct
EPS$1.35
Beat 10.7%
Q2 201020 Jul
EPS$1.31
Beat 17.0%
Q1 201020 Apr
EPS$1.08
Miss 4.4%
Q4 20099 Feb
EPS$1.20
Beat 14.3%
Q3 200920 Oct
EPS$1.12
Beat 7.7%
Q2 200916 Jul
EPS$0.75
Beat 10.3%
Q1 200916 Apr
EPS$1.05
Beat 5.0%
Q4 20086 Feb
EPS$0.93
Beat 0.0%
Q3 200821 Oct
EPS$0.98
Beat 8.9%
Q2 200822 Jul
EPS$0.91
Beat 7.1%
Q1 200823 Apr
EPS$0.83
Beat 5.1%
Q4 20076 Feb
EPS$0.89
Beat 11.3%
Q3 200723 Oct
EPS$0.58
Miss 10.8%
Q2 200724 Jul
EPS$0.70
Beat 11.1%
Q1 20072 May
EPS$0.59
Miss 3.3%
Q4 200615 Feb
EPS$0.53
Miss 3.6%
Q3 200631 Oct
EPS$0.60
Beat 22.4%
Q2 200626 Jul
EPS$0.57
Beat 16.3%
Q1 200626 Apr
EPS$0.55
Beat 14.6%
Q4 200515 Feb
EPS$0.48
Beat 2.1%
Q3 200526 Oct
EPS$0.36
Miss 14.3%
Q2 200526 Jul
EPS$0.43
Beat 19.4%
Q1 200527 Apr
EPS$0.30
Miss 16.7%
Q4 20047 Feb
EPS$0.29
Miss 19.4%
Q3 200427 Oct
EPS$0.37
Beat 5.7%
Q2 200428 Jul
EPS$0.34
Beat 6.3%
Q1 200430 Apr
EPS$0.40
Beat 17.6%
Q4 20032 Mar
EPS$0.24
Miss 25.0%
Q3 200314 Oct
EPS$0.26
Beat 4.0%
Q2 200317 Jul
EPS$0.24
Miss 7.7%
Q1 200315 Apr
EPS$0.24
Beat 0.0%
Q4 200230 Jan
EPS$0.26
Beat 0.0%
Q3 200216 Oct
EPS$0.22
Beat 4.8%
Q2 200217 Jul
EPS$0.20
Beat 5.3%
Q1 200218 Apr
EPS$0.17
Beat 6.3%
Q4 200129 Jan
EPS$0.16
Beat 0.0%
Q3 200118 Oct
EPS$0.16
Beat 0.0%
Q2 200119 Jul
EPS$0.15
Beat 0.0%
Q1 200119 Apr
EPS$0.12
Beat 0.0%
Q4 200029 Jan
EPS$0.12
Beat 9.1%
Q3 200016 Oct
EPS$0.10
Beat 0.0%
Q2 200018 Jul
EPS$0.09
Beat 12.5%
Q1 200020 Apr
EPS$0.02
Beat 2.4%
Q4 19992 Feb
EPS$0.05
Miss 28.6%
Q3 199918 Oct
EPS$0.07
Beat 0.0%
Q2 199922 Jul
EPS$0.13
Beat 0.0%
Q1 199920 Apr
EPS$0.04
Beat 42.5%
Q4 19989 Feb
EPS$0.05
Beat 20.8%
Q3 199820 Oct
EPS$0.02
Beat 199.8%
Q2 199820 Jul
EPS$0.09
Beat 50.0%
Q1 199820 Apr
EPS$0.03
Beat 152.5%
Q4 19975 Feb
EPS$0.06
Beat 20.0%
Q3 199711 Nov
EPS$-0.08
Miss 33.3%
Q2 19974 Aug
EPS$-0.04
Beat 42.9%
Q1 19978 May
EPS$-0.02
Beat 60.0%
Q4 199621 Feb
EPS$0.01
Beat 138.7%
Q3 199630 Oct
EPS$-0.04
Beat 20.0%
Q2 199625 Jul
EPS$-0.04
Miss 4.8%
Q1 19962 May
EPS$0.02
Beat 133.3%
Q4 199515 Feb
EPS$0.02
Beat 187.4%
Q3 199525 Oct
EPS$-0.05
Beat 0.0%
Q2 199525 Jul
EPS$-0.05
Beat 16.7%
Q1 19951 May
EPS$-0.12
Miss 71.4%
Q4 199416 Feb
EPS$-0.04
Beat 33.3%
Q3 199425 Oct
EPS$-0.07
Beat 0.0%
Q2 199426 Jul
EPS$-0.09
Beat 0.0%
Q1 199428 Apr
EPS$-0.09
Beat 0.0%
Q4 19931 Mar
EPS$-0.09
Miss 28.6%
Q3 199315 Nov
EPS$0.01
Beat 125.0%
Q2 199316 Aug
EPS$-0.06
Miss 20.0%
Q1 19937 May
EPS$0.05
Beat 200.0%
Q4 19928 Mar
EPS$-0.05
Beat 0.0%
Q3 199231 Dec
EPS$0.03
Q1 199230 Jun
EPS$0.00
Q4 199131 Mar
EPS$0.00
Q3 199131 Dec
EPS$0.00
Q2 199130 Sept
EPS$0.00
Q1 199130 Jun
EPS$0.00
Q4 199031 Mar
EPS$0.01
Q3 199031 Dec
EPS$0.01
Q2 199030 Sept
EPS$0.01
Q1 199030 Jun
EPS$0.03
Q4 198931 Mar
EPS$0.01
Q3 198931 Dec
EPS$0.01
Q2 198930 Sept
EPS$0.01
Q1 198930 Jun
EPS$-0.00
Q4 198831 Mar
EPS$0.00
Q3 198831 Dec
EPS$0.00
Q2 198830 Sept
EPS$0.00
Q1 198830 Jun
EPS$-0.00
Q4 198731 Mar
EPS$-0.00
Q3 198731 Dec
EPS$-0.01
Q2 198730 Sept
EPS$-0.01
Q1 198730 Jun
EPS$-0.01
Q4 198631 Mar
EPS$-0.01
Q3 198631 Dec
EPS$-0.02
Q2 198630 Sept
EPS$-0.02
Q1 198630 Jun
EPS$-0.01
Q4 198531 Mar
EPS$-0.01
Q3 198531 Dec
EPS$-0.02
Q2 198530 Sept
EPS$-0.01

1 politician traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

18 Jan 2001Stock Split
Ratio3:1
21 Dec 1999Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LLY

Eli Lilly and Company

47
$1008.39+18.06 (+1.82%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

NVDA

NVIDIA Corporation

20
$182.65+4.77 (+2.68%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.680.00 (0.00%)
Held by same politician
1 politician
View Stock
Pelosi TrackerJoin our Discord © 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.